Poster Session 1 and Drinks — ASN Events
7:30PM - 10:00PM
Manhattan Room
Sponsored by:


China Peptide Bank (#99)

7:30 PM
Michael Sullivan

Development of polyglutamic acid/chitosan-based intranasal peptide nanovaccine (#100)

7:30 PM
Reshma Jayprakash Nevagi

Structural mechanisms of atypical conotoxin modulators of the nicotinic acetylcholine receptors (#101)

7:30 PM
Nikita Abraham

Development and optimization of GLP-1 analogs with improved drug delivery characteristics through conjugation to other molecules using Copper(I)-catalysed azide-alkyne cycloaddition (CuAAC) chemistry (#102)

7:30 PM
Seyed Ebrahim Alavi

Liposomal Delivery System for Lipopeptide-based Vaccine against Group A Streptococcus Infection (#103)

7:30 PM
Nedaa Alharbi

Synergy between sortase A inhibitors and antimicrobial peptides against antibiotic resistant bacteria (#104)

7:30 PM
Sitah Muflih Al Harthi

A Computational study of the XLA peptide as an Akt-1 PH inhibitor (#105)

7:30 PM
Yasuri D. E. Amarasekara

Development of autophagy-inducing peptides as a potential therapy for motor neurone disease (#106)

7:30 PM
Azin Amin

Synthesis and anti-tumour activity of a neoantigen peptide vaccine (#107)

7:30 PM
Regan J Anderson

Macropinocytosis-inducing Peptide – Its Applications and Mechanism (#108)

7:30 PM
Jan Vincent V. Arafiles

Bile acid-liposomes as a new delivery system for peptide-based vaccine against Group A Streptococcus (#109)

7:30 PM
Armira Azuar

Pharmacokinetics and Biodistribution of HsTX1[R14A] in Mice (#110)

7:30 PM
Sanjeevini Babu Reddiar

Microinjection: An Approach for Assessing Cellular Toxicity of Peptide Modulators of Intracellular Protein-Protein Interactions (#111)

7:30 PM
Sanjeevini Babu Reddiar

Peptide Hydrogels for Pain (#112)

7:30 PM
Steven Ballet

Everything old is new again: the surprising utility of prodrugs for beyond rule-of-five compounds (#113)

7:30 PM
Nicholas Barlow

Tandem Domain Evasins: Inhibitors of Chemokine-mediated Inflammation (#114)

7:30 PM
Ram P Bhusal

Validation of Novel Modalities Targeting Protein: Protein Interactions using Mini-proteins  (#115)

7:30 PM
Christopher J Brown

Fmoc-Cys(Msbh) – a sophisticated building block for cysteine-rich peptides. A journey from discovery through to large scale production. (#116)

7:30 PM
Thomas Bruckdorfer

Short arginine analogs: peptide synthesis and prediction of biological effects (#117)

7:30 PM
Thomas Bruckdorfer

A peptide from Testudo horsfieldii tortoise spleen as a potential helper for reducing acute radiation syndrome. (#118)

7:30 PM
Gerardo Byk

 Native Chemical Ligation-Photodesulfurisation in Flow     (#119)

7:30 PM
Stephen A. Byrne

An efficient strategy for N-terminal modification of unprotected peptides by utilizing hydrophilic protecting groups (#120)

7:30 PM
Chaitra Dr Chandrashekar

Combined administration of PTX and s-HM-3 in TPGS/solutol micelle system for oncotarget therapy (#121)

7:30 PM
Xiaowei Chi

Rationally Designed α-Conotoxin Analogues Maintained Analgesia Activity and Weakened Side Effects (#122)

7:30 PM
Hanmei Xu

Functional Role of a Novel Long Noncoding RNA TTN-AS1 in Esophageal Squamous Cell Carcinoma Progression and Metastasis (#123)

7:30 PM
Hanmei Xu

Efficient Semisynthesis of Glycosyl-interferon-β (#124)

7:30 PM
Yie Kie Chong

Protein regulation at atomic resolution: Exploring the effects of posttranslational modifications on HMGN1 (#125)

7:30 PM
Anne C. Conibear

Exploring the sequence diversity of novel cyclotides from Vietnamese Viola species (#126)

7:30 PM
Tien Thuy Dang

Structure-Activity Relationships of Miniaturised α-Conotoxins (#127)

7:30 PM
James T Daniel

Downsizing promiscuous Bim BH3 domain into a potent, cell-permeable, selective inhibitor of oncogenic Bcl2A1 and Mcl-1 proteins (#128)

7:30 PM
Aline Dantas

Chemical synthesis of interferon gamma (#129)

7:30 PM
Yuankun Dao

Distinct structural and biological differences between the N- and C-terminal regions of granulins   (#130)

7:30 PM
Mohadeseh Dastpeyman

Synthesis of naturally occurring N-methylated cyclic tetrapeptides (#131)

7:30 PM
Emma K Davison

Genetically-encoded bicyclic architectures displayed on phage (#132)

7:30 PM
Ratmir Derda

Synthesis of Thrombin Inhibitors Bearing Acid-Stable Sulfotyrosine Mimics (#133)

7:30 PM
Luke J Dowman

Mechanism of the inhibitory interference in human antimicrobial peptides (#134)

7:30 PM
Ewa Drab

The widely used medicinal herbs Hybanthus enneaspermus F.Muell is rich in cyclotide with cytotoxic activity against cancer cell lines (#135)

7:30 PM
Qingdan Du

Synthesis of cyclic peptide inhibitors of FXIIa as novel anticoagulants (#136)

7:30 PM
Nisharnthi M. Duggan

Development of novel self-adjuvanting peptide-based subunit vaccine against herpes simplex virus-2 (#137)

7:30 PM
Viet Tram Duong

Plasticity of PDZ-dependent PSD-95 interactions (#138)

7:30 PM
Dominik Essig

Towards Cell-permeable Macrocycles using mRNA Display (#139)

7:30 PM
Wayne J Fairbrother

Development an oral based delivery system for peptide vaccine against Group A Streptococcus (GAS). (#140)

7:30 PM
Mohammad Omer Faruck

Optimization of a CXCR4 receptor mimetic peptide (#141)

7:30 PM
Karen Marlyse Fiebig

The Development of Linear and Cyclic Lipopeptide based Adjuvants (#142)

7:30 PM
Farrhana Firdaus

Precisely controlled intracellular trafficking and enhanced gene silencing of nucleic acid-peptide conjugates. (#143)

7:30 PM
Masayuki Fujii

Structure and function of O-GlcNAc/phosphorylation cross talk in Tau protein (#144)

7:30 PM
Neha S Gandhi

Novel analogues of Fengycin A with enhanced chemical stability (#145)

7:30 PM
Diana Gimenez-Ibanez

The design and development of a potent and selective C5aR1 agonist (#146)

7:30 PM
Declan M Gorman

Development of novel diketopiperazines as eco-friendly antifouling biocides (#147)

7:30 PM
Thomas M Grant

Structural parameters modulating the cellular uptake of a macrocyclic peptide from the common zinnia   (#148)

7:30 PM
Fatemeh H. Alipour

Controlling the assembly of D/L cyclic peptides through a linear scaffold (#149)

7:30 PM
Amanda Handrisanto

A novel approach to quantify oxytocin in biological samples via mass spectrometry (#150)

7:30 PM
Anke Hering

Chemical biology tools for the characterisation and the exploitation of antibiotic biosynthetic pathways (#151)

7:30 PM
Yee Ting Candace Ho

Exploiting the p21 template: Development of a broad-spectrum cancer diagnostic and peptidomimetic therapeutic with defined 310-helical structure (#152)

7:30 PM
Aimee J Horsfall

Glycopeptide vaccine based on DNA Supramolecular Hydrogels (#153)

7:30 PM
Hongguo Hu

Astratides: Insight into bioactive compounds in Chinese Medicine from Astragalus membranaceus  (#154)

7:30 PM
Jiayi Huang

Synthesis of Nanobody80 using SPPS (#155)

7:30 PM
Yara Huppelschoten

Polyacrylate-peptide liposomal formulation as a therapeutic vaccine candidate against cervical cancer (#156)

7:30 PM
Waleed M Hussein

Cell penetrating peptides to increase membrane permeability of larger cyclic peptides as inhibitors for protein-protein interactions  (#157)

7:30 PM
Soonsil Hyun

Fast peptide-MHC docking based with 3D Convolutional Neural Net (#158)

7:30 PM
Mikhail Ignatov

A ready-to-read on-bead peptide sequencing method using two-dimensional SERS encoders  (#159)

7:30 PM
Dae Hong Jeong

Chemcial synthesis of ubiquitinated histones for biochemical and structural analysis (#160)

7:30 PM
Li Jia-Bin

Transcriptomic-Proteomic Correlation in the Predation-Evoked Venom of the Cone Snail, Conus imperialis (#161)

7:30 PM
Ai-Hua (Jean) JIN

Applications of cyclotides in the pharmaceutical and agricultural industries (#162)

7:30 PM
Meng-Wei Kan

Reconstitution of non-ribosomal peptide synthesis in vitro: the story of teicoplanin biosynthesis (#163)

7:30 PM
Milda Kaniusaite

Unravelling the diversity and distribution of insect antimicrobial peptides (#164)

7:30 PM
Johannes Koehbach